Innovation Series 2021: Episode Six
EAGB Update with Simon Barnett (Analyst, ARK Invest)

Do you have any questions?

When: June 8th, 2021

Where: Anywhere you are! 


  • Simon Barnett (Analyst, ARK Invest)
  • Ren Leggi (Client Portfolio Manager, ARK Invest)
  • Dan White (Client Portfolio Specialist, ARK Invest)

Lisa Lake Langley, CEO & President, Emerge Canada Inc. sat down with Simon Barnett (Analyst, ARK Invest) to discuss the latest developments in genomics and biotechnology.

Here are some of the questions asked: 

  • Is CRISPRs gene editing becoming clinically important in cholesterol management?
  • What do you think will have the biggest impact on people’s livable years?
  • What are the risks of not achieving the key objects that you mentioned? Are there any barriers to the cost [of early cancer screening] dropping?